Showing results (51-60 of 106) with videos related to
Sort By:
Pageof 11
Seminars in Arthritis and Rheumatism|August 14, 2017
Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN)Léa Savey, Jean-Charles Piette, Jérome Bellanger, et al.Therapeutic Drug Monitoring|October 17, 2009
Pharmacokinetic-pharmacodynamic modeling of manganese after a single intravenous infusion of mangafodipir in patients with acute alcoholic hepatitisDéborah Hirt, Jean-Philippe Richardet, Saïk Urien, et al.AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|August 22, 2022
Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)Tangui Barré, Philippe Sogni, Olivia Zaegel-Faucher, et al.BMC Infectious Diseases|August 25, 2016
The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virusAndrew Richard Armstrong, Susan Elizabeth Herrmann, Olivier Chassany, et al.Journal of Hepatology|September 25, 2014
Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastographyThomas Deffieux, Jean-Luc Gennisson, Laurence Bousquet, et al.Hepatology (Baltimore, Md.)|December 21, 2018
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected PatientsDominique Salmon-Ceron, Pierre Nahon, Richard Layese, et al.British Journal of Clinical Pharmacology|January 29, 2023
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case reportAnthia Monribot, Olivier Huillard, Nihel Khoudour, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2010
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized studyJean-Pierre Zarski, Nathalie Sturm, Hervé Desmorat, et al.Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up of rare genetic liver diseasesRodolphe Sobesky, Olivier Guillaud, Charlotte Bouzbib, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|March 23, 2013
Management of hepatitis C virus infection in heavy drinkersCharlotte E Costentin, Jean-Baptiste Trabut, Vincent Mallet, et al.Pageof 11